Ebola, the world’s deadliest disease that leads to organ failure will be a soon preventable and treatable disease, BBC reported. For now, four drugs have been tested on the patients in the Democratic Republic of Congo were this a major outbreak of disease.
The research shows that if Ebola treated early in the stage of symptoms can be treatable. The US National Institute of Allergy and Infectious Diseases (NIAID) is co-sponsoring the research in the drugs said the trials are showing “very good results” in the trial that will be deneutralize the affected immune system.
Dr. Anthony Fauci, director of NIAID. said that the drugs named REGN-EB3 and mAb114 are one of the first drugs have shown “significant diminution in mortality”. The drugs were developed from the antibodies harvested from survivors of Ebola. The disease has killed more than 1,800 people last year.
Out of the four experimented drugs on 700 patients, the company called Regeneron Pharmaceuticals drug had the biggest impact on lowering death rates, down to 29 percent, while NIAID’s monoclonal antibody, called mAb114, had a mortality rate of 34 percent. Looking forward to the other two drugs, 49% on ZMapp and 53% on Remdesivir died in the study, the agency said.
From now on, we will no longer say that Ebola is incurable,” said Jean-Jacques Muyembe, director-general of the Institut National de Recherche Biomedicale in the DRC, which has overseen the trial’s operations on the ground. While WHO’s director of health emergencies Mr. Mike Ryan also commented on the news.
“Today’s news puts us one more step to saving more lives,” said Ryan. “The success is clear. But there’s also a tragedy linked to the success. The tragedy is that not enough people are being treated. We are still seeing too many people staying away from treatment centers, people not being found in time to benefit from these therapies.”